Colin Y
Unité INSERM U76, Institut National de la Transfusion Sanguine, Paris, France.
Transfus Clin Biol. 1995;2(4):259-68. doi: 10.1016/s1246-7820(05)80092-8.
Four main glycophorins which can be specifically detected by periodic-acid-Schiff (PAS) staining after separation of red cell membranes by SDS-polyacrylamide gel electrophoresis have been identified and are known under different nomenclatures. Here, the designation of glycophorins A, B and C and glycophorin D will be used. A new member designated glycophorin E (GPE) has been recently identified in the course of molecular genetic studies. These glycophorins represent about 2% of the total erythrocyte membrane protein mass and have been fully characterized both at the protein and at the DNA level. Accordingly, these molecules can be subdivided into two groups that are distinguished by distinct properties such as blood group antigenic properties, apparent M(r), copy number, attached glycans, detergent solubility, and gene structure. GPC and GPD are minor sialoglycoproteins contributing to 4 and 1% to the PAS-positive material and are present at about 2.0 and 0.5 x 10(5) copies/cell, respectively. Both carry blood group Gerbich (Ge) antigens. Protein and nucleic acid analysis indicated that GPD is a truncated form of GPC in its N-terminal region and that both proteins are produced by a unique gene which is present as a single copy on chromosome 2q14-q21. GPC and GPD are produced from the same gene through use of alternative translation initiation sites. These proteins and the GYPC gene share no homology with the GPA, GPB and GPE proteins and the GYPA gene cluster, respectively. Thus, the glycophorin name, which suggests that all these sialoglycopropteins have a common genetic origin, might be now considered as a misnomer. As a further difference between the two groups of membrane proteins, GPC and GPD are expressed both in erythroid and non erythroid tissues, but the level of transcription is much higher in erythroid than in non erythroid tissues and in addition the proteins are differently glycosylated in the two cell types. Increasing evidence suggests a significant role for GPC and GPD in the regulation of the red cell shape and the membrane mechanical properties by providing a membrane linkage site for cytoskeletal proteins, especially proteins 4.1 and p55. The total lack of GPC and GPD in the red cell membrane is associated with hereditary ellyptocytosis in the Leach phenotype and the molecular basis of these defects have been elucidated.(ABSTRACT TRUNCATED AT 400 WORDS)
通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳分离红细胞膜后,用高碘酸-希夫(PAS)染色可特异性检测到四种主要的血型糖蛋白,它们已被鉴定出来,并有不同的命名。在此,将使用血型糖蛋白A、B、C和血型糖蛋白D的命名。最近在分子遗传学研究过程中发现了一个新成员,命名为血型糖蛋白E(GPE)。这些血型糖蛋白约占红细胞膜蛋白总量的2%,在蛋白质和DNA水平上均已得到充分表征。因此,这些分子可分为两组,它们具有不同的特性,如血型抗原特性、表观分子量(M(r))、拷贝数、连接的聚糖、去污剂溶解度和基因结构。GPC和GPD是次要的唾液酸糖蛋白,分别占PAS阳性物质的4%和1%,每个细胞中约有2.0×10(5)和0.5×10(5)个拷贝。两者都携带Gerbich(Ge)血型抗原。蛋白质和核酸分析表明,GPD是GPC在其N端区域的截短形式,这两种蛋白质由位于2号染色体q14-q21上的单拷贝独特基因产生。GPC和GPD通过使用不同的翻译起始位点由同一基因产生。这些蛋白质和GYPC基因分别与GPA、GPB和GPE蛋白质以及GYPA基因簇没有同源性。因此,血型糖蛋白这个名称,暗示所有这些唾液酸糖蛋白有共同的遗传起源,现在可能被认为是一个误称。作为两组膜蛋白的另一个区别,GPC和GPD在红细胞和非红细胞组织中均有表达,但在红细胞中的转录水平远高于非红细胞组织,此外,这两种细胞类型中蛋白质的糖基化方式也不同。越来越多的证据表明,GPC和GPD通过为细胞骨架蛋白,尤其是4.1蛋白和p55蛋白提供膜连接位点,在调节红细胞形状和膜机械性能方面发挥重要作用。红细胞膜中完全缺乏GPC和GPD与Leach表型的遗传性椭圆形红细胞增多症有关,这些缺陷的分子基础已得到阐明。(摘要截短至400字)